Page last updated: 2024-09-22

2-ethylhexanal

Cross-References

ID SourceID
PubMed CID31241
CHEMBL ID1558074
CHEBI ID87809
SCHEMBL ID15760
MeSH IDM0121000

Synonyms (64)

Synonym
2-ethylhexaldehyde
hexanal, 2-ethyl-
3-formylheptane
123-05-7
2-ethylhexylaldehyde
2-ethylcaproaldehyde
wln: vhy4 & 2
nsc-42871
ethylbutylacetaldehyde
2-ethylhexanal ,
nsc42871
ethylhexaldehyde
.alpha.-ethylcaproaldehyde
butylethylacetaldehyde
NCGC00091728-01
brn 1700556
alpha-ethylcaproaldehyde
nsc 42871
ai3-26805
beta-propyl-alpha-ethylacrolein
hsdb 5142
ccris 4643
einecs 204-596-5
butyl ethyl acetaldehyde
2-ethylhexanal, 96%
2-ethylhexyl aldehyde
E0125
STK801684
AKOS005607756
NCGC00091728-02
ec 204-596-5
4-01-00-03345 (beilstein handbook reference)
sen8s34o6u ,
unii-sen8s34o6u
tox21_303326
NCGC00256965-01
dtxcid005291
dtxsid9025291 ,
cas-123-05-7
tox21_202095
NCGC00259644-01
BBL010642
2-ethyl-hexanal
FT-0612272
.alpha.-ethylhexanal
2-ethylhexylaldehyde [hsdb]
2-ethylhexanal, (+/-)-
caproaldehyde, .alpha.-ethyl-
.beta.-propyl-.alpha.-ethylacrolein
SCHEMBL15760
2-ethylhexan-1-al
CHEMBL1558074
chebi:87809 ,
2-ethyl hexanal
2-eh
ethylhexanal
J-660018
alpha-ethylhexanal
2-ethylhexanal, analytical standard
mfcd00006987
VS-02601
Q209379
2-ethylcapronaldehyde
EN300-321440

Roles (2)

RoleDescription
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
saturated fatty aldehydeA fatty aldehyde in which there is no carbon-carbon unsaturation.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.03160.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency19.52790.003041.611522,387.1992AID1159552
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency30.94970.001530.607315,848.9004AID1224841
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency5.79250.023723.228263.5986AID743223
aryl hydrocarbon receptorHomo sapiens (human)Potency77.74210.000723.06741,258.9301AID743085
survival motor neuron protein isoform dHomo sapiens (human)Potency12.58930.125912.234435.4813AID1458
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]